Transcatheter Aortic Valve Replacement With Early- and New-Generation Devices in Bicuspid Aortic Valve Stenosis

Journal of the American College of Cardiology

Volumn 68, Issue 11, 2016, Pages 1195-1205

  Yoon, Sung Han ^a   Lefèvre, Thierry ^b   Ahn, Jung Ming ^a   Perlman, Gidon Y ^c   Dvir, Danny ^c   Latib, Azeem ^d   Barbanti, Marco ^e   Deuschl, Florian ^f   De Backer, Ole ^g   Blanke, Philipp ^c   Modine, Thomas ^h   Pache, Gregor ⁱ   Neumann, Franz Josef ^j   Ruile, Philipp ^j   Arai, Takahide ^b   Ohno, Yohei ^e   Kaneko, Hidehiro ^k   Tay, Edgar ^l   Schofer, Niklas ^f   Holy, Erik W ^m   Luk, Ngai H V ^g   Yong, Gerald ⁿ   Lu, Qingsheng ^o   Kong, William K F ^l,p   Hon, Jimmy ^l   Kao, Hsien Li ^q   Lee, Michael ^r   Yin, Wei Hsian ^s   Park, Duk Woo ^a   Kang, Soo Jin ^a   Lee, Seung Whan ^a   Kim, Young Hak ^a   Lee, Cheol Whan ^a   Park, Seong Wook ^a   Kim, Hyo Soo ^t   Butter, Christian ^k   Khalique, Omar K ^u   Schaefer, Ulrich ^f   Nietlispach, Fabian ^m   Kodali, Susheel K ^u   Leon, Martin B ^u   Ye, Jian ^c   Chevalier, Bernard ^b   Leipsic, Jonathon ^c   Delgado, Victoria ^q   Bax, Jeroen J ^q   Tamburino, Corrado ^e   Colombo, Antonio ^d   Søndergaard, Lars ^g   Webb, John G ^c   Park, Seung Jung ^a   more..

^a University of Ulsan   (South Korea)

^b INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e UNIVERSITY OF CATANIA   (Italy)

^f UNIVERSITY HEART CENTER HAMBURG   (Germany)

^g International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^h LILLE UNIVERSITY HOSPITAL   (France)

ⁱ UNIVERSITY OF FREIBURG   (Germany)

^j UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^k Heart Centre Brandenburg   (Germany)

^l NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^m UNIVERSITY HOSPITAL ZURICH   (Switzerland)

ⁿ ROYAL PERTH HOSPITAL   (Australia)

^o SECOND MILITARY MEDICAL UNIVERSITY   (China)

^p LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^q NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^r QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^s CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^t Seoul National University Hospital   (South Korea)

^u NEW YORK PRESBYTERIAN HOSPITAL   (United States)

more..

Author keywords

mortality; new device; paravalvular leak

Indexed keywords

ACUTE KIDNEY FAILURE; AGED; ALL CAUSE MORTALITY; AORTA VALVE PROSTHESIS; AORTA VALVE STENOSIS; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE SAFETY; DISEASE SEVERITY; EUROSCORE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PARAVALVULAR LEAK; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOCIETY OF THORACIC SURGEONS SCORE; TRANSCATHETER AORTIC VALVE IMPLANTATION; VASCULAR DISEASE; ABNORMALITIES; AORTIC VALVE; AORTIC VALVE STENOSIS; CLINICAL TRIAL; COMPLICATION; DEVICES; EQUIPMENT DESIGN; HEART VALVE DISEASES;

AGED; AORTIC VALVE; AORTIC VALVE STENOSIS; EQUIPMENT DESIGN; FEMALE; HEART VALVE DISEASES; HUMANS; MALE; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84994910749     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.06.041     Document Type: Article

References (43)

1. 1 Kodali, S.K., Williams, M.R., Smith, C.R., et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 366 (2012), 1686–1695.
2. 2 Makkar, R.R., Fontana, G.P., Jilaihawi, H., et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 366 (2012), 1696–1704.
3. 3 Gilard, M., Eltchaninoff, H., Iung, B., et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 366 (2012), 1705–1715.
4. 4 Hamm, C.W., Mollmann, H., Holzhey, D., et al. The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J 35 (2014), 1588–1598.
5. 5 Moat, N.E., Ludman, P., de Belder, M.A., et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 58 (2011), 2130–2138.
6. 6 Adams, D.H., Popma, J.J., Reardon, M.J., et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370 (2014), 1790–1798.
7. 7 Siu, S.C., Silversides, C.K., Bicuspid aortic valve disease. J Am Coll Cardiol 55 (2010), 2789–2800.
8. 8 Himbert, D., Pontnau, F., Messika-Zeitoun, D., et al. Feasibility and outcomes of transcatheter aortic valve implantation in high-risk patients with stenotic bicuspid aortic valves. Am J Cardiol 110 (2012), 877–883.
9. 9 Zhao, Z.G., Jilaihawi, H., Feng, Y., Chen, M., Transcatheter aortic valve implantation in bicuspid anatomy. Nat Rev Cardiol 12 (2015), 123–128.
10. 10 Webb, J., Gerosa, G., Lefevre, T., et al. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol 64 (2014), 2235–2243.
11. 11 Husser, O., Pellegrini, C., Kessler, T., et al. Outcomes after transcatheter aortic valve replacement using a novel balloon-expandable transcatheter heart valve: a single-center experience. J Am Coll Cardiol Intv 8 (2015), 1809–1816.
12. 12 Meredith Am, I.T., Walters, D.L., Dumonteil, N., et al. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study. J Am Coll Cardiol 64 (2014), 1339–1348.
13. 13 Meredith, I.T., Walters, D.L., Dumonteil, N., et al. 1-Year outcomes with the fully repositionable and retrievable Lotus transcatheter aortic replacement valve in 120 high-risk surgical patients with severe aortic stenosis. J Am Coll Cardiol Intv 9 (2016), 376–384.
14. 14 Rampat, R., Khawaja, M.Z., Byrne, J., et al. Transcatheter aortic valve replacement using the repositionable LOTUS valve. J Am Coll Cardiol Intv 9 (2016), 367–372.
15. 15 Thilo, C., Shivaraju, A., von Scheidt, W., Kasel, A.M., Bicuspid aortic valve stenosis with successful transfemoral transcatheter aortic valve replacement (TAVI) using the Sapien 3 valve. Eur Heart J, 35, 2014, 2662.
16. 16 Seeger, J., Gonska, B., Rodewald, C., Rottbauer, W., Wohrle, J., Bicuspid aortic stenosis treated with the repositionable and retrievable Lotus Valve. Can J Cardiol 32 (2016), 135.e17–135.e19.
17. 17 Perlman, G.Y., Blanke, P., Dvir, D., et al. Bicuspid aortic valve stenosis: favorable early outcomes with a next-generation transcatheter heart valve in a multicenter study. J Am Coll Cardiol Intv 9 (2016), 817–824.
18. 18 Sievers, H.H., Schmidtke, C., A classification system for the bicuspid aortic valve from 304 surgical specimens. J Thorac Cardiovasc Surg 133 (2007), 1226–1233.
19. 19 Cribier, A., Eltchaninoff, H., Tron, C., et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 47 (2006), 1214–1223.
20. 20 Webb, J.G., Pasupati, S., Humphries, K., et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 116 (2007), 755–763.
21. 21 Ye, J., Cheung, A., Lichtenstein, S.V., et al. Transapical transcatheter aortic valve implantation: 1-year outcome in 26 patients. J Thorac Cardiovasc Surg 137 (2009), 167–173.
22. 22 Grube, E., Laborde, J.C., Gerckens, U., et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 114 (2006), 1616–1624.
23. 23 Etienne, P.Y., Papadatos, S., El Khoury, E., Pieters, D., Price, J., Glineur, D., Transaortic transcatheter aortic valve implantation with the Edwards SAPIEN valve: feasibility, technical considerations, and clinical advantages. Ann Thorac Surg 92 (2011), 746–748.
24. 24 Bruschi, G., de Marco, F., Botta, L., et al. Direct aortic access for transcatheter self-expanding aortic bioprosthetic valves implantation. Ann Thorac Surg 94 (2012), 497–503.
25. 25 Kappetein, A.P., Head, S.J., Genereux, P., et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 60 (2012), 1438–1454.
26. 26 Mylotte, D., Lefevre, T., Sondergaard, L., et al. Transcatheter aortic valve replacement in bicuspid aortic valve disease. J Am Coll Cardiol 64 (2014), 2330–2339.
27. 27 Yousef, A., Simard, T., Webb, J., et al. Transcatheter aortic valve implantation in patients with bicuspid aortic valve: A patient level multi-center analysis. Int J Cardiol 189 (2015), 282–288.
28. 28 Amat-Santos, I.J., Dahou, A., Webb, J., et al. Comparison of hemodynamic performance of the balloon-expandable SAPIEN 3 versus SAPIEN XT transcatheter valve. Am J Cardiol 114 (2014), 1075–1082.
29. 29 Murray, M.I., Geis, N., Pleger, S.T., et al. First experience with the new generation Edwards Sapien 3 aortic bioprosthesis: procedural results and short term outcome. J Interv Cardiol 28 (2015), 109–116.
30. 30 Abdel-Wahab, M., Zahn, R., Horack, M., et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart 97 (2011), 899–906.
31. 31 Kodali, S., Pibarot, P., Douglas, P.S., et al. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards Sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J 36 (2015), 449–456.
32. 32 Abdel-Wahab, M., Comberg, T., Buttner, H.J., et al. Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience. J Am Coll Cardiol Intv 7 (2014), 284–292.
33. 33 Jilaihawi, H., Kashif, M., Fontana, G., et al. Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol 59 (2012), 1275–1286.
34. 34 Willson, A.B., Webb, J.G., Labounty, T.M., et al. 3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. J Am Coll Cardiol 59 (2012), 1287–1294.
35. 35 Binder, R.K., Webb, J.G., Willson, A.B., et al. The impact of integration of a multidetector computed tomography annulus area sizing algorithm on outcomes of transcatheter aortic valve replacement: a prospective, multicenter, controlled trial. J Am Coll Cardiol 62 (2013), 431–438.
36. 36 Mylotte, D., Dorfmeister, M., Elhmidi, Y., et al. Erroneous measurement of the aortic annular diameter using 2-dimensional echocardiography resulting in inappropriate CoreValve size selection: a retrospective comparison with multislice computed tomography. J Am Coll Cardiol Intv 7 (2014), 652–661.
37. 37 Yoon, S.H., Ahn, J.M., Ohno, Y., et al. Predictors for paravalvular regurgitation after TAVR with the self-expanding prosthesis: quantitative measurement of MDCT analysis. J Am Coll Cardiol Img, 2015 Dec 30 [E-pub ahead of print].
38. 38 Tan, J.S., Leipsic, J., Perlman, G., et al. A strategy of underexpansion and ad hoc post-dilation of balloon-expandable transcatheter aortic valves in patients at risk of annular injury: favorable mid-term outcomes. J Am Coll Cardiol Intv 8 (2015), 1727–1732.
39. 39 Yang, T.H., Webb, J.G., Blanke, P., et al. Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT. J Am Coll Cardiol Intv 8 (2015), 462–471.
40. 40 Tarantini, G., Mojoli, M., Purita, P., et al. Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. EuroIntervention 11 (2015), 343–350.
41. 41 Husser, O., Pellegrini, C., Kessler, T., et al. Predictors of permanent pacemaker implantations and new-onset conduction abnormalities with the SAPIEN 3 balloon-expandable transcatheter heart valve. J Am Coll Cardiol Intv 9 (2016), 244–254.
42. 42 Steinvil, A., Leshem-Rubinow, E., Halkin, A., et al. Vascular complications after transcatheter aortic valve implantation and their association with mortality reevaluated by the valve academic research consortium definitions. Am J Cardiol 115 (2015), 100–106.
43. 43 Genereux, P., Webb, J.G., Svensson, L.G., et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol 60 (2012), 1043–1052.